Literature DB >> 11533107

Validation of the ucla integrated staging system for patients with renal cell carcinoma.

A Zisman, A J Pantuck, R A Figlin, A S Belldegrun.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11533107     DOI： 10.1200/JCO.2001.19.17.3792

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers.

Authors:  Sumanta Kumar Pal; Marcin Kortylewski; Hua Yu; Robert A Figlin
Journal:  Mol Cancer Ther       Date:  2010-11-15       Impact factor: 6.261

Review 2.  Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.

Authors:  Giovanni M Frascà; Fabiana Brigante; Alessandro Volpe; Laura Cosmai; Maurizio Gallieni; Camillo Porta
Journal:  J Nephrol       Date:  2018-10-16       Impact factor: 3.902

3.  Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.

Authors:  Primo N Lara; Catherine M Tangen; Sarah J Conlon; Robert C Flanigan; E David Crawford
Journal:  J Urol       Date:  2008-12-18       Impact factor: 7.450

4.  Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.

Authors:  Xiwei Wu; Lihong Weng; Xuejun Li; Chao Guo; Sumanta K Pal; Jennifer M Jin; Yuping Li; Rebecca A Nelson; Bing Mu; Susan H Onami; Jeffrey J Wu; Nora H Ruel; Sharon P Wilczynski; Hanlin Gao; Maricela Covarrubias; Robert A Figlin; Lawrence M Weiss; Huiqing Wu
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

5.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec

Review 6.  From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.

Authors:  Androu Arsanious; Georg A Bjarnason; George M Yousef
Journal:  Mol Cancer       Date:  2009-03-17       Impact factor: 27.401

7.  Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer.

Authors:  Meijun Du; Karthik V Giridhar; Yijun Tian; Michael R Tschannen; Jing Zhu; Chiang-Ching Huang; Deepak Kilari; Manish Kohli; Liang Wang
Journal:  Oncotarget       Date:  2017-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.